Kuzel T - Search Results

1

Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma.

Stadler WM, Kuzel T, Shapiro C, Sosman J, Clark J, Vogelzang NJ. Stadler WM, et al. Among authors: kuzel t. J Clin Oncol. 1999 Aug;17(8):2541-5. doi: 10.1200/JCO.1999.17.8.2541. J Clin Oncol. 1999. PMID: 10561320 Clinical Trial.

2

Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy.

Kuzel TM, Roenigk HH Jr, Rosen ST. Kuzel TM, et al. J Clin Oncol. 1991 Jul;9(7):1298-313. doi: 10.1200/JCO.1991.9.7.1298. J Clin Oncol. 1991. PMID: 2045869 Review.

3

Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sézary syndrome.

Kuzel TM, Roenigk HH Jr, Samuelson E, Herrmann JJ, Hurria A, Rademaker AW, Rosen ST. Kuzel TM, et al. J Clin Oncol. 1995 Jan;13(1):257-63. doi: 10.1200/JCO.1995.13.1.257. J Clin Oncol. 1995. PMID: 7799028 Clinical Trial.

4

A phase II study of continuous infusion 5-fluorouracil in advanced hormone refractory prostate cancer. An Illinois Cancer Center Study.

Kuzel TM, Tallman MS, Shevrin D, Braud E, Kilton L, Johnson P, Kozlowski J, Vogelzang NJ, Blough R, Benson AB 3rd. Kuzel TM, et al. Cancer. 1993 Sep 15;72(6):1965-8. doi: 10.1002/1097-0142(19930915)72:6<1965::aid-cncr2820720629>3.0.co;2-x. Cancer. 1993. PMID: 8364875 Clinical Trial.

5

Metastatic bladder cancer: advances in treatment.

Stadler WM, Kuzel TM, Raghavan D, Levine E, Vogelzang NJ, Roth B, Dorr FA. Stadler WM, et al. Among authors: kuzel tm. Eur J Cancer. 1997 Jan;33 Suppl 1:S23-6. doi: 10.1016/s0959-8049(96)00337-1. Eur J Cancer. 1997. PMID: 9166096 Review.

6

A phase II trial of edatrexate in patients with advanced renal cell carcinoma. An Eastern Cooperative Oncology Group study.

Dreicer R, Propert KJ, Kuzel T, Kirkwood JM, O'Dwyer PJ, Loehrer PJ. Dreicer R, et al. Among authors: kuzel t. Am J Clin Oncol. 1997 Jun;20(3):251-3. doi: 10.1097/00000421-199706000-00008. Am J Clin Oncol. 1997. PMID: 9167747 Clinical Trial.

7

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.

Stadler WM, Kuzel T, Roth B, Raghavan D, Dorr FA. Stadler WM, et al. Among authors: kuzel t. J Clin Oncol. 1997 Nov;15(11):3394-8. doi: 10.1200/JCO.1997.15.11.3394. J Clin Oncol. 1997. PMID: 9363871 Clinical Trial.

8

Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma.

Stadler WM, Kuzel T, Dumas M, Vogelzang NJ. Stadler WM, et al. Among authors: kuzel t. J Clin Oncol. 1998 May;16(5):1820-5. doi: 10.1200/JCO.1998.16.5.1820. J Clin Oncol. 1998. PMID: 9586896 Clinical Trial.

9

Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials.

Ryan CW, Vogelzang NJ, Dumas MC, Kuzel T, Stadler WM. Ryan CW, et al. Among authors: kuzel t. Cancer. 2000 Mar 15;88(6):1317-24. Cancer. 2000. PMID: 10717612 Clinical Trial.

10

Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.

Kaufman D, Raghavan D, Carducci M, Levine EG, Murphy B, Aisner J, Kuzel T, Nicol S, Oh W, Stadler W. Kaufman D, et al. Among authors: kuzel t. J Clin Oncol. 2000 May;18(9):1921-7. doi: 10.1200/JCO.2000.18.9.1921. J Clin Oncol. 2000. PMID: 10784633 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters